amaxa - Part of the Lonza Group
 
 
You are not logged in. Log in

The Nucleofector Technology and Stable Protein Production

Stable transfection is an inevitable prerequisite for therapeutic and large scale protein production. Growth in suspension is preferred in order to simplify cultivation conditions and up-scaling needs. For many suspension cell lines though, the transfection efficiency using conventional transfection methods is not sufficient to facilitate the direct generation of stable clones with both good growth and production properties.

With the help of Nucleofector Technology the cell line of interest can be transfected directly in suspension and in a serum-free environment with excellent efficiencies. This enables generation of stable high-producer clones even from difficult-to-transfect suspension cell lines and facilitates a significant shortening of overall process time.

Benefit from stable protein production using nucleofection:

   

Download amaxa's Guideline for Generation of Stable Cell Lines

If you are interested in getting detailed technical information on how to establish stable cell lines, log in to download amaxa's comprehensive guideline.